萊蒙國際(03688.HK)2019年盈轉虧至5.82億港元
格隆匯3月31日丨萊蒙國際(03688.HK)公告,截至2019年12月31日止年度的收入增加約16.1%至約7.19億港元。
截至2019年12月31日止年度,公司權益股東應占虧損約為5.82億港元(截至2018年12月31日止年度:公司權益股東應占盈利約為1.02億港元)。於2019年12月31日,集團的淨負債比率由2018年12月31日約29.5%增加至約50.0%。
董事會已建議向公司權益股東及永久可換股證券持有人派發截至2019年12月31日止年度的末期股息每股2港仙(截至2018年12月31日止年度:每股6港仙)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.